A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis
Clinical trial NCT03998683 · COMPLETED
Trial details
- NCT number
- NCT03998683
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2021-03-02
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.